584 related articles for article (PubMed ID: 2822101)
21. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
Nephron; 1997; 75(3):286-94. PubMed ID: 9069450
[TBL] [Abstract][Full Text] [Related]
22. Characterization of apoA- and apoB-containing lipoprotein particles in a variant of familial apoA-I deficiency with planar xanthoma: the metabolic significance of LP-A-II particles.
Bekaert ED; Alaupovic P; Knight-Gibson CS; Laux MJ; Pelachyk JM; Norum RA
J Lipid Res; 1991 Oct; 32(10):1587-99. PubMed ID: 1797940
[TBL] [Abstract][Full Text] [Related]
23. Lipid transport in the avian species. Part I. Isolation and characterization of apolipoproteins and major lipoprotein density classes of male turkey serum.
Kelley JL; Alaupovic P
Atherosclerosis; 1976; 24(1-2):155-75. PubMed ID: 182183
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia.
Alaupovic P; Knight-Gibson C; Wang CS; Downs D; Koren E; Brewer HB; Gregg RE
J Lipid Res; 1991 Jan; 32(1):9-19. PubMed ID: 1901345
[TBL] [Abstract][Full Text] [Related]
25. The enhanced association of apolipoprotein E with apolipoprotein B-containing lipoproteins in serum-stimulated hepatocytes occurs intracellularly.
Fazio S; Yao Z
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):593-600. PubMed ID: 7749873
[TBL] [Abstract][Full Text] [Related]
26. Effect of ethanol on the synthesis and secretion of apoA-I- and apoB-containing lipoproteins in HepG2 cells.
Dashti N; Franklin FA; Abrahamson DR
J Lipid Res; 1996 Apr; 37(4):810-24. PubMed ID: 8732781
[TBL] [Abstract][Full Text] [Related]
27. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
[TBL] [Abstract][Full Text] [Related]
28. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
29. Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I.
Musliner TA; Long MD; Forte TM; Nichols AV; Gong EL; Blanche PJ; Krauss RM
J Lipid Res; 1991 Jun; 32(6):917-33. PubMed ID: 1940624
[TBL] [Abstract][Full Text] [Related]
30. Characterization of apolipoprotein B-containing lipoproteins separated by preparative free flow isotachophoresis.
Nowicka G; Brüning T; Grothaus B; Kahl G; Schmitz G
J Lipid Res; 1990 Jul; 31(7):1173-86. PubMed ID: 2401852
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
32. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro.
Tam SP; Dory L; Rubinstein D
J Lipid Res; 1981 May; 22(4):641-51. PubMed ID: 7276737
[TBL] [Abstract][Full Text] [Related]
33. Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency.
Ikewaki K; Cain W; Thomas F; Shamburek R; Zech LA; Usher D; Brewer HB; Rader DJ
J Lipid Res; 2004 Jul; 45(7):1302-11. PubMed ID: 15102883
[TBL] [Abstract][Full Text] [Related]
34. The assembly and secretion of apolipoprotein B-48-containing very low density lipoproteins in McA-RH7777 cells.
Stillemark P; Borén J; Andersson M; Larsson T; Rustaeus S; Karlsson KA; Olofsson SO
J Biol Chem; 2000 Apr; 275(14):10506-13. PubMed ID: 10744742
[TBL] [Abstract][Full Text] [Related]
35. Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2.
Dashti N; Wolfbauer G
Biochim Biophys Acta; 1986 Feb; 875(3):473-86. PubMed ID: 3004589
[TBL] [Abstract][Full Text] [Related]
36. Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells.
Macri J; Adeli K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2982-94. PubMed ID: 9409285
[TBL] [Abstract][Full Text] [Related]
37. HepG2 cell LDL receptor activity and the accumulation of apolipoprotein B and E in response to docosahexaenoic acid and cholesterol.
Sorci-Thomas M; Hendricks CL; Kearns MW
J Lipid Res; 1992 Aug; 33(8):1147-56. PubMed ID: 1431595
[TBL] [Abstract][Full Text] [Related]
38. Long-term effects of cis and trans monounsaturated (18:1) and saturated (16:0) fatty acids on the synthesis and secretion of apolipoprotein A-I- and apolipoprotein B-containing lipoproteins in HepG2 cells.
Dashti N; Feng Q; Franklin FA
J Lipid Res; 2000 Dec; 41(12):1980-90. PubMed ID: 11108731
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein and lipid distribution between vesicles and HDL-like particles formed during lipolysis of human very low density lipoproteins by perfused rat heart.
Tam SP; Breckenridge WC
J Lipid Res; 1983 Oct; 24(10):1343-57. PubMed ID: 6644185
[TBL] [Abstract][Full Text] [Related]
40. Effect of thyroid hormone on plasma apolipoproteins and apoA- and apoB-containing lipoprotein particles.
Liu XQ; Rahman A; Bagdade JD; Alaupovic P; Kannan CR
Eur J Clin Invest; 1998 Apr; 28(4):266-70. PubMed ID: 9615901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
